ロード中...
A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
We have examined the effects of 1,25 dihydroxyvitamin D3 (1,25[OH]2D3) and a low calcemic analogue EB1089 on parathyroid hormone-related peptide (PTHRP) production and on the development of hypercalcemia in Fischer rats implanted with the Leydig cell tumor H-500. Leydig cell tumors were implanted su...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
1993
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC443300/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8514854/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116475 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|